KND / Kindred Healthcare, Inc. - Documents déposés auprès de la SEC, rapport annuel, procuration

KND / Kindred Healthcare, Inc. FORM 15

15-12B 1 d472447d1512b.htm FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-14057 Kindred Healthcare, LLC (succe

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

S-8 POS 1 d663244ds8pos.htm POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

KND / Kindred Healthcare, Inc. POST-EFFECTIVE AMEND. NO. 1 TO FORM S-8

Post-Effective Amend. No. 1 to Form S-8 As filed with the Securities and Exchange Commission on July 2, 2018 Registration No. 333-51363 Registration No. 333-51361 Registration No. 333-59598 Registration No. 333-62022 Registration No. 333-88086 Registration No. 333-116755 Registration No. 333-151580 Registration No. 333-174615 Registration No. 333-183269 Registration No. 333-197755 Registration No.

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2018 KINDRED HEALTHCARE, LLC (successor in interest to Kindred Healthcare, Inc.) (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993

Initial Limited Liability Company Agreement of Kindred Healthcare, LLC. (**)

EX-3.3 Exhibit 3.3 EXECUTION VERSION LIMITED LIABILITY COMPANY AGREEMENT OF KINDRED HEALTHCARE, LLC This Limited Liability Company Agreement (this “Agreement”) of Kindred Healthcare, LLC, a Delaware limited liability company (the “Company”), is made, entered into and effective as of July 2, 2018 by Kentucky Homecare Intermediate, Inc., a Delaware corporation, as the sole member (the “Member”). WIT

Certificate of Formation of Kindred Healthcare, LLC. (**)

EX-3.2 Exhibit 3.2 CERTIFICATE OF FORMATION OF Kindred Healthcare, LLC 1. The name of the limited liability company is Kindred Healthcare, LLC 2. The address of its registered office in the State of Delaware is: Corporation Trust Center, 1209 Orange Street, in the City of Wilmington, Delaware 19801. The name of its registered agent at such address is The Corporation Trust Company. IN WITNESS WHERE

Amended and Restated Certificate of Incorporation of Kindred Healthcare, Inc. (**)

EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF KINDRED HEALTHCARE, INC. ARTICLE ONE The name of the Company is Kindred Healthcare, Inc. (the “Company”). ARTICLE TWO The registered office of the Company in the State of Delaware is located at Suite 302, 4001 Kennett Pike, Wilmington, County of New Castle, Delaware 19807, and the name of the registered agent whose office addr

Amended and Restated Limited Liability Company Agreement of Kindred Healthcare, LLC. (**)

EX-3.4 Exhibit 3.4 EXECUTION VERSION AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF KINDRED HEALTHCARE, LLC This Amended and Restated Limited Liability Company Agreement (this “Agreement”) of Kindred Healthcare, LLC, a Delaware limited liability company (the “Company”), is made, entered into and effective as of the Effective Time (as defined below) on July 2, 2018 by and between Kentu

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on July 13, 2018, pursuant to the provisions of Rule 12d2-2 (a).

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or or

Explanation of Kindred

EX-99.1 Exhibit 99.1 Appendix Explanation of Kindred Non-GAAP Measures In addition to the results provided in accordance with GAAP, Kindred Healthcare, Inc. (the “Company”) has provided information in this presentation using certain non-GAAP measures. The use of these non-GAAP measures is not intended to replace the presentation of the Company’s financial results in accordance with GAAP. Reconcili

KND / Kindred Healthcare, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Amendment No. 3 to the Second Amended and Restated Master Lease Agreement No. 5, among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc., and Ventas Realty, Limited Partnership.

EXHIBIT 10.1 AMENDMENT NO. 3 TO THE SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 THIS AMENDMENT NO. 3 TO THE SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 is effective as of March 27, 2018 (this “Amendment”), by and among Kindred Healthcare, Inc., a Delaware corporation (“Kindred”), Kindred Healthcare Operating, Inc., a Delaware corporation and direct, wholly-owned subsidiar

KND / Kindred Healthcare, Inc. / JP Morgan Chase & Co - NONE Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 01)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, par value $0.25 per share (Title of Class of Securities) 494580103 (CUSIP Number) April 30, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de

KND / Kindred Healthcare, Inc. 10-K/A (Annual Report)

10-K/A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K/A (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14057 KINDRED HEALTHCARE, INC.

Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or o

KINDRED STOCKHOLDERS APPROVE TRANSACTION WITH TPG CAPITAL, WELSH, CARSON, ANDERSON & STOWE AND HUMANA INC. Transaction Expected to Close in Summer of 2018

EX-99.1 Exhibit 99.1 KINDRED STOCKHOLDERS APPROVE TRANSACTION WITH TPG CAPITAL, WELSH, CARSON, ANDERSON & STOWE AND HUMANA INC.

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ De

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ De

KND / Kindred Healthcare, Inc. / BRIGADE CAPITAL MANAGEMENT, LP Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value per share (Title of Class of Securities) 494580103 (CUSIP Number) Aaron Michael Daniels, Esq. Brigade Capital Management, LP 399 Park Ave, 16th Floor New York, NY 10022 (212) 745-970

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ De

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ De

KND / Kindred Healthcare, Inc. / BRIGADE CAPITAL MANAGEMENT, LP Activist Investment

SC 13D/A 1 d785002913d-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value per share (Title of Class of Securities) 494580103 (CUSIP Number) Aaron Michael Daniels, Esq. Brigade Capital Management, LP 399 Park Ave, 16th Floor New

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ De

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A 1 d536514ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permi

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A 1 d551783ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permi

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ De

KND / Kindred Healthcare, Inc. / BRIGADE CAPITAL MANAGEMENT, LP Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value per share (Title of Class of Securities) 494580103 (CUSIP Number) Aaron Michael Daniels, Esq. Brigade Capital Management, LP 399 Park Ave, 16th Floor New York, NY 10022 (212) 745-970

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A 1 d545724ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permi

KND / Kindred Healthcare, Inc. 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14057 KINDRED HEALTHCARE, INC.

List of Subsidiaries

EXHIBIT 21 REGISTRANT’S SUBSIDIARIES December 31, 2017 Cornerstone Insurance Company, a Cayman Islands corporation Kindred Healthcare Operating, Inc.

Amendment No. 1 to Second Amended and Restated Master Lease Agreement No. 5, dated as of November 7, 2017.

EXHIBIT 10.33 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 THIS AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 (hereinafter, this “Amendment”) is executed, and effective, as of November 7, 2017 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership (together with its success

KINDRED HEALTHCARE REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS Consolidated Revenues of $1.5 Billion, GAAP Loss from Continuing Operations of $135 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $1.65(1), and EBITDA Loss o

Exhibit 99.1 Exhibit 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS Consolidated Revenues of $1.5 Billion, GAAP Loss from Continuing Operations of $135 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $1.65(1), and EBITDA Loss of $193 Million(2) in the Fourth Quarter Core EBITDA of $119 Million(

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

KND / Kindred Healthcare, Inc. DEFA14A

DEFA14A 1 d543681ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule

Investor Presentation February 2018

EX-99.1 Exhibit 99.1 Investor Presentation February 2018 Forward Looking Statements This presentation includes ?forward-looking statements? within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are often identified by words such as ?anticipate,? ?approximate,? ?believe,? ?pla

KINDRED HEALTHCARE, INC.

EX-99.2 Exhibit 99.2 KINDRED HEALTHCARE, INC. February 21, 2018 Dear Stockholder: Kindred recently announced a value maximizing merger transaction, and we are asking for your support in advance of the upcoming Special Meeting of Stockholders that has been scheduled for March 29, 2018. The Kindred Board of Directors is confident that the transaction, which follows a robust 18-month process, is in t

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or or

Letter to Stockholders dated February 21, 2018

EX-99.2 Exhibit 99.2 KINDRED HEALTHCARE, INC. February 21, 2018 Dear Stockholder: Kindred recently announced a value maximizing merger transaction, and we are asking for your support in advance of the upcoming Special Meeting of Stockholders that has been scheduled for March 29, 2018. The Kindred Board of Directors is confident that the transaction, which follows a robust 18-month process, is in t

Investor Presentation made available by Kindred Healthcare, Inc. on February 21, 2018

EX-99.1 Exhibit 99.1 Investor Presentation February 2018 Forward Looking Statements This presentation includes ?forward-looking statements? within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are often identified by words such as ?anticipate,? ?approximate,? ?believe,? ?pla

KND / Kindred Healthcare, Inc. 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or or

KND / Kindred Healthcare, Inc. DEFINITIVE PROXY STATEMENT

DEFM14A 1 d511414ddefm14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the

KND / Kindred Healthcare, Inc. / VANGUARD GROUP INC Passive Investment

kindredhealthcareinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: Kindred Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 494580103 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropri

KND / Kindred Healthcare, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* KINDRED HEALTHCARE INC (Name of Issuer) Common Stock (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

KND / Kindred Healthcare, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 8 )* Kindred Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 494580103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation o

Investor Presentation February 2018

EX-99.1 Exhibit 99.1 Investor Presentation February 2018 Forward Looking Statements This presentation includes ?forward-looking statements? within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are often identified by words such as ?anticipate,? ?approximate,? ?believe,? ?pla

Investor Presentation made available by Kindred Healthcare, Inc. on February 5, 2018

EX-99.1 Exhibit 99.1 Investor Presentation February 2018 Forward Looking Statements This presentation includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are often identified by words such as “anticipate,” “approximate,” “believe,” “pla

KND / Kindred Healthcare, Inc. FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2018 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation o

KND / Kindred Healthcare, Inc. PRELIMINARY PROXY STATEMENT

Preliminary Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

KND / Kindred Healthcare, Inc. / VANGUARD EXPLORER FUND Passive Investment

kindredhealthcareinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.:0 )* Name of issuer: Kindred Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 494580103 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropria

KND / Kindred Healthcare, Inc. / BRIGADE CAPITAL MANAGEMENT, LP Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1 )* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value per share (Title of Class of Securities) 494580103 (CUSIP Number) Aaron Michael Daniels, Esq. Brigade Capital Management, LP 399 Park Ave, 16th Floor New York, NY 10022 (212) 745-97

KND / Kindred Healthcare, Inc. / JP Morgan Chase & Co - NONE Passive Investment

Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* KINDRED HEALTHCARE, INC. (Name of Issuer) Common stock, $0.25 par value (Title of Class of Securities) 494580103 (CUSIP Number) December 29, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa

KND / Kindred Healthcare, Inc. / BRIGADE CAPITAL MANAGEMENT, LP Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value per share (Title of Class of Securities) 494580103 (CUSIP Number) Aaron Michael Daniels, Esq. Brigade Capital Management, LP 399 Park Ave, 16th Floor New York, NY 10022 (212) 745-9700

December 27, 2017

Exhibit 1 December 27, 2017 Benjamin A. Breier President and Chief Executive Officer Kindred Healthcare, Inc. 680 South Fourth Street Louisville, Kentucky 40202 CC: The Board of Directors Re: Announced Acquisition of Kindred Healthcare by TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc. for $9.00 Per Share in Cash Dear Mr. Breier: As large and long-term shareholders of Kindred Healthca

Separation Agreement, dated as of December 19, 2017, among Kindred Healthcare, Inc., Kentucky Hospital Holdings, LLC, Kentucky Homecare Holdings, Inc. and Kentucky Hospital Merger Sub, Inc.

EX-10.1 EXHIBIT 10.1 EXECUTION VERSION SEPARATION AGREEMENT by and among KINDRED HEALTHCARE, INC., KENTUCKY HOMECARE HOLDINGS, INC., KENTUCKY HOSPITAL HOLDINGS, LLC, and KENTUCKY HOSPITAL MERGER SUB, INC. Dated as of December 19, 2017 Table of Contents Page ARTICLE I SEPARATION TRANSACTIONS Section 1.01 KNCLP Contribution 2 Section 1.02 KNCE Merger 2 Section 1.03 Conversion to Limited Liability Co

Agreement and Plan of Merger, dated as of December 19, 2017, among Kindred Healthcare, Inc., Kentucky Hospital Holdings, LLC, Kentucky Homecare Holdings, Inc. and Kentucky Homecare Merger Sub, Inc.*

EX-2.1 EXHIBIT 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among KENTUCKY HOSPITAL HOLDINGS, LLC, KENTUCKY HOMECARE HOLDINGS, INC., KENTUCKY HOMECARE MERGER SUB, INC. and KINDRED HEALTHCARE, INC. dated as of DECEMBER 19, 2017 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.01. The Merger 2 Section 1.02. Closing 2 Section 1.03. Effective Time 3 Section 1.04. Effects of the Merger 3 Sectio

Amendment No. 2 to the Second Amended and Restated Master Lease Agreement No. 5

EX-10.2 EXHIBIT 10.2 EXECUTION VERSION AMENDMENT NO. 2 TO THE SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 THIS AMENDMENT NO. 2 TO THE SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 is made and entered into as of December 19, 2017 (this ?Amendment?), by and among Kindred Healthcare, Inc., a Delaware corporation (?Kentucky?), Kindred Healthcare Operating, Inc., a Delaware corp

Amendment to Amended and Restated Bylaws of Kindred Healthcare, Inc.

EX-3.1 EXHIBIT 3.1 Amendment to Amended and Restated Bylaws of Kindred Healthcare, Inc. The Amended and Restated Bylaws of Kindred Healthcare, Inc. be and hereby are amended by the addition of a new Section 6.8 thereto, to read in its entirety as follows: Section 6.8. Exclusive Forum; Personal Jurisdiction. (a) Unless the Corporation consents in writing to the selection of an alternative forum, th

KND / Kindred Healthcare, Inc. FORM 8-K (Current Report)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

KND / Kindred Healthcare, Inc. FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

Agreement and Plan of Merger, dated as of December 19, 2017, among Kindred Healthcare, Inc., Kentucky Hospital Holdings, LLC, Kentucky Homecare Holdings, Inc. and Kentucky Homecare Merger Sub, Inc.*

EX-2.1 EXHIBIT 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER among KENTUCKY HOSPITAL HOLDINGS, LLC, KENTUCKY HOMECARE HOLDINGS, INC., KENTUCKY HOMECARE MERGER SUB, INC. and KINDRED HEALTHCARE, INC. dated as of DECEMBER 19, 2017 TABLE OF CONTENTS ARTICLE I THE MERGER 2 Section 1.01. The Merger 2 Section 1.02. Closing 2 Section 1.03. Effective Time 3 Section 1.04. Effects of the Merger 3 Sectio

Separation Agreement, dated as of December 19, 2017, among Kindred Healthcare, Inc., Kentucky Hospital Holdings, LLC, Kentucky Homecare Holdings, Inc. and Kentucky Hospital Merger Sub, Inc.

EX-10.1 EXHIBIT 10.1 EXECUTION VERSION SEPARATION AGREEMENT by and among KINDRED HEALTHCARE, INC., KENTUCKY HOMECARE HOLDINGS, INC., KENTUCKY HOSPITAL HOLDINGS, LLC, and KENTUCKY HOSPITAL MERGER SUB, INC. Dated as of December 19, 2017 Table of Contents Page ARTICLE I SEPARATION TRANSACTIONS Section 1.01 KNCLP Contribution 2 Section 1.02 KNCE Merger 2 Section 1.03 Conversion to Limited Liability Co

Amendment to Amended and Restated Bylaws of Kindred Healthcare, Inc.

EX-3.1 EXHIBIT 3.1 Amendment to Amended and Restated Bylaws of Kindred Healthcare, Inc. The Amended and Restated Bylaws of Kindred Healthcare, Inc. be and hereby are amended by the addition of a new Section 6.8 thereto, to read in its entirety as follows: Section 6.8. Exclusive Forum; Personal Jurisdiction. (a) Unless the Corporation consents in writing to the selection of an alternative forum, th

Amendment No. 2 to the Second Amended and Restated Master Lease Agreement No. 5

EX-10.2 EXHIBIT 10.2 EXECUTION VERSION AMENDMENT NO. 2 TO THE SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 THIS AMENDMENT NO. 2 TO THE SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 is made and entered into as of December 19, 2017 (this ?Amendment?), by and among Kindred Healthcare, Inc., a Delaware corporation (?Kentucky?), Kindred Healthcare Operating, Inc., a Delaware corp

We are excited to announce that Kindred’s Board of Directors approved a definitive agreement under which Kindred will be acquired by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe (“WCAS”) and Humana. The transaction wi

EX-99.4 5 d513446dex994.htm EX-99.4 Exhibit 99.4 We are excited to announce that Kindred’s Board of Directors approved a definitive agreement under which Kindred will be acquired by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe (“WCAS”) and Humana. The transaction will create two separate, privately-held companies. In connection with the acquisition of Kindred, our

KINDRED HEALTHCARE TO BE ACQUIRED BY TPG CAPITAL, WELSH, CARSON, ANDERSON & STOWE AND HUMANA INC. FOR $9.00 PER SHARE IN CASH Transaction Valued at Approximately $4.1 Billion; 27 Percent Premium to 90-Day VWAP Transaction Will Result in Two Separate

EX-99.1 Exhibit 99.1 KINDRED HEALTHCARE TO BE ACQUIRED BY TPG CAPITAL, WELSH, CARSON, ANDERSON & STOWE AND HUMANA INC. FOR $9.00 PER SHARE IN CASH Transaction Valued at Approximately $4.1 Billion; 27 Percent Premium to 90-Day VWAP Transaction Will Result in Two Separate Companies Kindred at Home Will Enhance Access to Care and Reduce Costs for People Living with Chronic Conditions Specialty Hospit

Dear INSERT:

EX-99.3 Exhibit 99.3 Dear INSERT: I am reaching out with some exciting news about our company. Kindred announced that it is being acquired and will become two private companies. Kindred?s IRFs, contract rehabilitation services and LTAC hospitals will become a specialty hospital company, Kindred Healthcare, owned by TPG Capital and Welsh, Carson, Anderson & Stowe (?WCAS?). Our home health, hospice

KND / Kindred Healthcare, Inc. FORM 8-K (Current Report)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

Page 1 of 5

EX-99.2 Exhibit 99.2 Kindred Ben Breier Video Transcript ? Hi everyone and happy holidays. We have some exciting news about the evolution of Kindred, and I?m proud to be able to share it with you today. Let me take some time to walk through this next chapter and what I believe it means for our company, our patients and of course all of you. ? Today, we announced that Kindred will become two separa

Please feel free to print this out and post it on your facility bulletin board. Also feel free to share this information with our physicians and colleagues in your next regularly scheduled staff meeting. KINDRED HEALTHCARE’S MISSION is to promote hea

EX-99.5 Exhibit 99.5 GREETINGS, I am writing today with some very exciting news about the future of our company. First, I want to thank you for all that you do each day to improve the lives of our patients. With the holiday season in full swing and the New Year quickly approaching, I know this is a busy time for everyone. I am grateful for your continued focus on excellent care delivery and the di

KND / Kindred Healthcare, Inc. FORM 8-K

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

“Moving Forward” FAQs, dated December 19, 2017.

EX-99.4 Exhibit 99.4 We are excited to announce that Kindred?s Board of Directors approved a definitive agreement under which Kindred will be acquired by a consortium of three companies: TPG Capital, Welsh, Carson, Anderson & Stowe (?WCAS?) and Humana. The transaction will create two separate, privately-held companies. In connection with the acquisition of Kindred, our home health, hospice and com

Transcript of video sent to Kindred employees by President and CEO Ben Breier.

EX-99.2 Exhibit 99.2 Kindred Ben Breier Video Transcript ? Hi everyone and happy holidays. We have some exciting news about the evolution of Kindred, and I?m proud to be able to share it with you today. Let me take some time to walk through this next chapter and what I believe it means for our company, our patients and of course all of you. ? Today, we announced that Kindred will become two separa

“Touching Base,” email to Kindred employees from President and CEO Ben Breier, dated December 19, 2017.

EX-99.5 6 d513446dex995.htm EX-99.5 Exhibit 99.5 GREETINGS, I am writing today with some very exciting news about the future of our company. First, I want to thank you for all that you do each day to improve the lives of our patients. With the holiday season in full swing and the New Year quickly approaching, I know this is a busy time for everyone. I am grateful for your continued focus on excell

Press release, dated December 19, 2017.

EX-99.1 Exhibit 99.1 KINDRED HEALTHCARE TO BE ACQUIRED BY TPG CAPITAL, WELSH, CARSON, ANDERSON & STOWE AND HUMANA INC. FOR $9.00 PER SHARE IN CASH Transaction Valued at Approximately $4.1 Billion; 27 Percent Premium to 90-Day VWAP Transaction Will Result in Two Separate Companies Kindred at Home Will Enhance Access to Care and Reduce Costs for People Living with Chronic Conditions Specialty Hospit

Letter to partners, dated December 19, 2017.

EX-99.3 Exhibit 99.3 Dear INSERT: I am reaching out with some exciting news about our company. Kindred announced that it is being acquired and will become two private companies. Kindred’s IRFs, contract rehabilitation services and LTAC hospitals will become a specialty hospital company, Kindred Healthcare, owned by TPG Capital and Welsh, Carson, Anderson & Stowe (“WCAS”). Our home health, hospice

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 d495796d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdicti

KINDRED PROVIDES UPDATE ON ADDITIONAL TRANSACTION CLOSINGS FOR ITS SKILLED NURSING FACILITY BUSINESS DIVESTITURE Sale Proceeds from the Recent Transaction Closings Approximated $31 Million Recent Transaction Closings Covered 12 Skilled Nursing Facili

EX-99.1 Exhibit 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED PROVIDES UPDATE ON ADDITIONAL TRANSACTION CLOSINGS FOR ITS SKILLED NURSING FACILITY BUSINESS DIVESTITURE Sale Proceeds from the Recent Transaction Closings Approximated $31 Million Recent Transaction Closings Covered 12 Skilled Nursing Facilities and One Assisted Living Facility Held for Sale Company has Completed

KINDRED HEALTHCARE REPORTS THIRD QUARTER 2017 RESULTS Consolidated Revenues of $1.48 Billion, GAAP Loss from Continuing Operations of $18 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $0.33(1), EBITDAR of $141 Million(2) and E

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS THIRD QUARTER 2017 RESULTS Consolidated Revenues of $1.48 Billion, GAAP Loss from Continuing Operations of $18 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $0.33(1), EBITDAR of $141 Million(2) and EBITDA of $66 Million(3) in the Third Quarter Results Reflect After-Tax Co

KND / Kindred Healthcare, Inc. FORM 8-K (Current Report)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Amendment to the Fourth Amended and Restated ABL Credit Agreement dated as of September 27, 2017 by and among Kindred Healthcare, Inc., the Consenting Lenders party thereto and JPMorgan Chase Bank, N.A. as administrative agent (incorporated by reference to Exhibit 10.1 to Kindred’s Form 10-Q for the quarterly period ended September 30, 2017 (Comm. File No. 001-14057)).

EXHIBIT 10.1 AMENDMENT TO THE FOURTH AMENDED AND RESTATED ABL CREDIT AGREEMENT dated as of September 27, 2017 (this ?Amendment?), among KINDRED HEALTHCARE, INC., a Delaware corporation (the ?Borrower?), the CONSENTING LENDERS (as defined below) and JPMorgan Chase bank, N.A., as administrative agent (the ?Administrative Agent?). RECITALS A.The Borrower, the Lenders party thereto from time to time a

Kindred Healthcare FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

Unaudited pro forma condensed consolidated financial information

EX-99.1 2 d461883dex991.htm EX-99.1 Exhibit 99.1 Unaudited pro forma condensed consolidated financial information On June 30, 2017, Kindred Healthcare, Inc. (“Kindred” or the “Company”) entered into a definitive agreement with BM Eagle Holdings, LLC, a joint venture led by affiliates of BlueMountain Capital Management, LLC (“BlueMountain”), under which the Company is selling its skilled nursing fa

KINDRED COMPLETES ADDITIONAL TRANSACTION CLOSING FOR ITS SKILLED NURSING FACILITY BUSINESS DIVESTITURE Sale Proceeds from the Additional Transaction Closing Approximated $108 Million Transaction Closing Covered 12 Skilled Nursing Facilities and Four

EX-99.2 3 d461883dex992.htm EX-99.2 EXHIBIT 99.2 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED COMPLETES ADDITIONAL TRANSACTION CLOSING FOR ITS SKILLED NURSING FACILITY BUSINESS DIVESTITURE Sale Proceeds from the Additional Transaction Closing Approximated $108 Million Transaction Closing Covered 12 Skilled Nursing Facilities and Four Assisted Living Facilities Held for Sale LOUI

Regulation FD Disclosure, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

KINDRED PROVIDES ESTIMATED IMPACT OF HURRICANES IRMA AND HARVEY

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Treasurer and Senior Vice President, Investor Relations (502) 596-6569 KINDRED PROVIDES ESTIMATED IMPACT OF HURRICANES IRMA AND HARVEY LOUISVILLE, Ky. (September 20, 2017) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that the Company expects a one-time pretax earnings impact from Hurricanes Irma and Harvey of approxim

KINDRED COMPLETES FIRST CLOSING FOR ITS SKILLED NURSING FACILITY BUSINESS DIVESTITURE Sale Proceeds from the Closing Approximated $519 Million Closing Covered 54 of the 89 Skilled Nursing Facilities Held for Sale

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED COMPLETES FIRST CLOSING FOR ITS SKILLED NURSING FACILITY BUSINESS DIVESTITURE Sale Proceeds from the Closing Approximated $519 Million Closing Covered 54 of the 89 Skilled Nursing Facilities Held for Sale LOUISVILLE, Ky. (August 31, 2017) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today ann

Kindred Healthcare FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or

Kindred Healthcare ESP

CORRESP August 30, 2017 Via EDGAR United States Securities and Exchange Commission 100 F Street, NE Washington, D.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ☐ TRANSITION REPORT PURSUANT TO SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Kindred Healthcare ESP

CORRESP 1 filename1.htm August 9, 2017 Via EDGAR United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attn: Mr. Carlos Pacho, Senior Assistant Chief Accountant AD Office 11 - Telecommunications Re: Kindred Healthcare, Inc. Form 10-K for Fiscal Year Ended December 31, 2016 Filed February 28, 2017 File No. 001-14057 Dear Mr. Pacho: Kindred Healthcare, Inc. (“Kindr

Kindred Healthcare FORM 8-K/A (Current Report/Significant Event)

Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 2 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdictio

Kindred Healthcare FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or

KINDRED HEALTHCARE REPORTS SECOND QUARTER 2017 RESULTS Results Adjusted to Reflect Discontinued Operations Accounting Treatment for Skilled Nursing Facility Business Consolidated Revenues of $1.53 Billion, GAAP Loss from Continuing Operations of $108

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS SECOND QUARTER 2017 RESULTS Results Adjusted to Reflect Discontinued Operations Accounting Treatment for Skilled Nursing Facility Business Consolidated Revenues of $1.53 Billion, GAAP Loss from Continuing Operations of $108 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $1

Submission of Matters to a Vote of Security Holders

Form 8-K Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other j

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or o

Asset Purchase Agreement dated as of June 30, 2017 by and between Kindred Healthcare Operating, Inc. and BM Eagle Holdings, LLC (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on July 3, 2017 (Comm. File No. 001-14057)).

EX-2.1 Exhibit 2.1 Execution Version ASSET PURCHASE AGREEMENT by and between KINDRED HEALTHCARE OPERATING, INC. and BM EAGLE HOLDINGS, LLC Dated as of June 30, 2017 TABLE OF CONTENTS ARTICLE I CERTAIN DEFINITIONS 1 1.1 Defined Terms 1 1.2 Terms Generally 12 ARTICLE II PURCHASE AND SALE OF ASSETS 12 2.1 Sale of Assets 12 2.2 Excluded Assets 13 2.3 Assumption of Liabilities 15 2.4 Excluded Liabiliti

KINDRED ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST SKILLED NURSING FACILITY BUSINESS Total Value to Kindred Will Approximate $910 Million Net Value to Kindred Will Approximate $210 Million Following Previously Announced $700 Million Real Estate Purchas

EX-99.1 3 d408906dex991.htm EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED ANNOUNCES DEFINITIVE AGREEMENT TO DIVEST SKILLED NURSING FACILITY BUSINESS Total Value to Kindred Will Approximate $910 Million Net Value to Kindred Will Approximate $210 Million Following Previously Announced $700 Million Real Estate Purchase from Ventas, Inc. Kindred’s Annual Rent Exp

Costs Associated with Exit or Disposal Activities

Form 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdictio

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

8-K 1 d396195d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction o

KINDRED HEALTHCARE ANNOUNCES VOTING RESULTS FOR THE 2017 ANNUAL MEETING OF SHAREHOLDERS

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE ANNOUNCES VOTING RESULTS FOR THE 2017 ANNUAL MEETING OF SHAREHOLDERS LOUISVILLE, Ky. (May 24, 2017) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced the voting results of the Company?s 2017 Annual Meeting of Shareholders held on May 24, 2017. At the annual meeting, the

Kindred Healthcare FORM S-8

Form S-8 As filed with the Securities and Exchange Commission on May 24, 2017 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or org

KINDRED HEALTHCARE REPORTS FIRST QUARTER 2017 RESULTS Consolidated Revenues of $1.77 Billion, GAAP Income from Continuing Operations of $9 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $0.07(1) and EBITDAR of $202 Million(2) i

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS FIRST QUARTER 2017 RESULTS Consolidated Revenues of $1.77 Billion, GAAP Income from Continuing Operations of $9 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $0.07(1) and EBITDAR of $202 Million(2) in the First Quarter Core EBITDAR of $218 Million(3) and Core Diluted EPS

Kindred Healthcare DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) ? De

Kindred Healthcare, Inc. Equity Plan for Non-Employee Directors, Amended and Restated (incorporated by reference to Annex B to the Company’s Definitive Proxy Statement on Schedule 14A filed on April 4, 2017 (Comm. File No. 001-14057)).

Definitive Proxy Statement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

Kindred Healthcare FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or

Sixth Amendment and Restatement Agreement dated as of March 14, 2017, by and among Kindred Healthcare, Inc., the Consenting Lenders (as defined therein) and JPMorgan Chase Bank, N.A., as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 14, 2017 (Comm. File No. 001-14057)).

Exhibit 10.1 Exhibit 10.1 EXECUTION VERSION SIXTH AMENDMENT AND RESTATEMENT AGREEMENT TO THE FIFTH AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENT dated as of March 14, 2017 (this ?Amendment?), among KINDRED HEALTHCARE, INC., a Delaware corporation (the ?Borrower?), the CONSENTING LENDERS (as defined below) and JPMORGAN CHASE BANK, N.A., as administrative agent and collateral agent (the ?Administr

KINDRED HEALTHCARE REPORTS FOURTH QUARTER 2016 RESULTS Consolidated Revenues of $1.75 Billion, GAAP Loss from Continuing Operations of $6 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $0.23(1) and EBITDAR of $190 Million(2) in

EX-99.1 Exhibit 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS FOURTH QUARTER 2016 RESULTS Consolidated Revenues of $1.75 Billion, GAAP Loss from Continuing Operations of $6 Million(1), GAAP Diluted Loss Per Share from Continuing Operations of $0.23(1) and EBITDAR of $190 Million(2) in the Fourth Quarter Core EBITDAR of $215 Million(3) and Core Diluted EPS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14057 KINDRED HEALTHCARE, INC.

AMENDED AND RESTATED EMPLOYMENT AGREEMENT

EXHIBIT 10.27 AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the ?Agreement?) is made on November 15, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?), and Michael W. Beal (the "Executive"). W I T N E S S E T H: WHEREAS, the Executive is employed by the Company, a wholly-owned subsidiar

REGISTRANT’S SUBSIDIARIES January 3, 2017

EXHIBIT 21 REGISTRANT?S SUBSIDIARIES January 3, 2017 Cornerstone Insurance Company, a Cayman Islands corporation Kindred Healthcare Operating, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2017 KINDRED HEALTHC

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2017 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE Company to Discontinue Cash Dividend on Common Shares Following March 31 P

EXHIBIT 99.2 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE Company to Discontinue Cash Dividend on Common Shares Following March 31 Payment and Redirect Funds to Repay Debt and Invest in Growth LOUISVILLE, Ky. (Feb

KND / Kindred Healthcare, Inc. / North Tide Capital Master, LP - AMENDMENT NO. 3 Passive Investment

SC 13G/A 1 sc13ga.htm AMENDMENT NO. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number:3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value (Title of Class of Securities) 49

KND / Kindred Healthcare, Inc. / VANGUARD GROUP INC Passive Investment

kindredhealthcareinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Kindred Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 494580103 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropri

KND / Kindred Healthcare, Inc. / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* KINDRED HEALTHCARE INC (Name of Issuer) Common Stock (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

KND / Kindred Healthcare, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7 )* Kindred Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 494580103 (CUSIP Number) December 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th

KINDRED ANNOUNCES AGREEMENTS WITH VENTAS FACILITATING STRATEGIC EXIT FROM SKILLED NURSING FACILITY BUSINESS

EX-99.1 7 d285135dex991.htm EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED ANNOUNCES AGREEMENTS WITH VENTAS FACILITATING STRATEGIC EXIT FROM SKILLED NURSING FACILITY BUSINESS LOUISVILLE, Ky. (November 14, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has entered into agreements with Ventas, Inc. (“Ventas”) (NY

AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 4

EX-10.4 EXHIBIT 10.4 AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 4 THIS AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 4 (hereinafter, this “Amendment”) is executed as of November 11, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership (together with its successors and

AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1

EX-10.2 EXHIBIT 10.2 AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1 THIS AMENDMENT NO. 4 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1 (hereinafter, this “Amendment”) is executed as of November 11, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership (together with its successors and

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2016 KINDRED HEALTHC

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

Second Amended and Restated Master Lease Agreement No. 5, dated as of November 11, 2016, among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc. and Ventas Realty, Limited Partnership (incorporated by reference to Exhibit 10.5 to Kindred’s Current Report on Form 8-K filed on November 14, 2016) (Comm. File No. 001-14057)).

EX-10.5 EXHIBIT 10.5 SECOND AMENDED AND RESTATED M A S T E R L E A S E A G R E E M E N T NO. 5 DATED AS OF NOVEMBER 11, 2016 EXECUTED BY VENTAS REALTY, LIMITED PARTNERSHIP, AS LESSOR AND KINDRED HEALTHCARE, INC. AND KINDRED HEALTHCARE OPERATING, INC., AS TENANT TABLE OF CONTENTS ARTICLE I 2 Section 1.1 Leased Property 2 Section 1.2 Term 3 Section 1.3 Successor Lease 3 Section 1.4 ML1/2/4 Amendment

AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 2

EX-10.3 EXHIBIT 10.3 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 2 THIS AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 2 (hereinafter, this “Amendment”) is executed as of November 11, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership (together with its successors and

Agreement Regarding Master Leases No. 3, dated as of November 11, 2016, among Kindred Healthcare, Inc., Kindred Healthcare Operating, Inc. and Ventas Realty, Limited Partnership (incorporated by reference to Exhibit 10.1 to Kindred’s Current Report on Form 8-K filed on November 14, 2016).

EX-10.1 EXHIBIT 10.1 AGREEMENT REGARDING MASTER LEASES NO. 3 THIS AGREEMENT REGARDING MASTER LEASES NO. 3 (hereinafter, this “Agreement”) is dated as of the 11th day of November, 2016 (the “ARML Effective Date”), and is between VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership (together with its successors and assigns, “Lessor”), and KINDRED HEALTHCARE, INC., a Delaware corporatio

Change-in-Control Severance Agreement dated as of August 15, 2016 by and between Kindred Healthcare Operating, Inc. and Jason P. Zachariah (incorporated by reference to Exhibit 10.2 to Kindred’s Form 10-Q for the quarterly period ended September 30, 2016 (Comm. File No. 001-14057)).

EXHIBIT 10.2 Change-in-Control Severance Agreement This Change-in-Control Severance Agreement (the ?Agreement?) is made as of the 15th day of August, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?) and JASON P. ZACHARIAH (the ?Employee?). Recitals: A. The Employee is employed by the Company, a wholly owned subsidiary of Kindred

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

Employment Agreement dated as of August 15, 2016 by and between Kindred Healthcare Operating, Inc. and Jason P. Zachariah (incorporated by reference to Exhibit 10.1 to Kindred’s Form 10-Q for the quarterly period ended September 30, 2016 (Comm. File No. 001-14057)).

EXHIBIT 10.1 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the ?Agreement?) is made as of the 15th day of August, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?), and Jason P. Zachariah (the "Executive"). W I T N E S S E T H: WHEREAS, the Executive is employed by the Company, a wholly-owned subsidiary of Kindred Healthcare, I

KINDRED HEALTHCARE UPDATES STRATEGY AND REPORTS THIRD QUARTER 2016 RESULTS Announces Plan to Exit the Skilled Nursing Facility Business; Announces Associated $70 Million to $100 Million Cost Realignment Initiative(1) Enterprise Strategy Focused on St

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE UPDATES STRATEGY AND REPORTS THIRD QUARTER 2016 RESULTS Announces Plan to Exit the Skilled Nursing Facility Business; Announces Associated $70 Million to $100 Million Cost Realignment Initiative(1) Enterprise Strategy Focused on Stronger Cash Flow, Higher Margin, Lower Capital Intensity Businesses Third

KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE

EXHIBIT 99.2 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE LOUISVILLE, Ky. (November 7, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors approved

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2016 KINDRED HEALTHCA

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation o

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation o

KINDRED ANNOUNCES APPOINTMENT OF DR. LYNN SIMON TO BOARD OF DIRECTORS

EX-99.1 Exhibit 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED ANNOUNCES APPOINTMENT OF DR. LYNN SIMON TO BOARD OF DIRECTORS LOUISVILLE, Ky. (November 2, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors has appointed Dr. Lynn Simon to the Board, effective immediately. Since 2

KINDRED COMPLETES SALE OF 12 LTAC HOSPITALS TO CURAHEALTH, ADVANCING LTAC PORTFOLIO OPTIMIZATION STRATEGY

EX-99.1 Exhibit 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED COMPLETES SALE OF 12 LTAC HOSPITALS TO CURAHEALTH, ADVANCING LTAC PORTFOLIO OPTIMIZATION STRATEGY LOUISVILLE, Ky. (October 3, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that it has completed its previously announced agreement to sell 12 long-term acute care (?LTAC?) ho

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 16, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or organ

KINDRED APPOINTS JASON ZACHARIAH AS PRESIDENT OF KINDRED REHABILITATION SERVICES

EX-99.1 Exhibit 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED APPOINTS JASON ZACHARIAH AS PRESIDENT OF KINDRED REHABILITATION SERVICES LOUISVILLE, Ky. (August 15, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the appointment of Jason Zachariah as President of Kindred Rehabilitation Services (“KRS”),

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 d242554d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdictio

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 d242554d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdictio

KINDRED APPOINTS JASON ZACHARIAH AS PRESIDENT OF KINDRED REHABILITATION SERVICES

EX-99.1 Exhibit 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED APPOINTS JASON ZACHARIAH AS PRESIDENT OF KINDRED REHABILITATION SERVICES LOUISVILLE, Ky. (August 15, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the appointment of Jason Zachariah as President of Kindred Rehabilitation Services (“KRS”),

AMENDMENT NO. 4 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5

EXHIBIT 10.6 AMENDMENT NO. 4 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 This Amendment No. 4 to Amended and Restated Master Lease Agreement No. 5 (this ?Amendment?) is entered into as of June 21, 2016, by and between: (a) Ventas Realty, Limited Partnership, a Delaware limited partnership (?Lessor?); (b) Kindred Healthcare, Inc., a Delaware corporation (?Kindred?), and Kindred Healthcare

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 ¨ TRANSITION REPORT PURSUANT TO SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

EMPLOYEE RETENTION AGREEMENT

EXHIBIT 10.7 EMPLOYEE RETENTION AGREEMENT This Employee Retention Agreement (?Agreement?), dated as of May 9, 2016, is by and between Kindred Healthcare Operating, Inc. (the ?Company?) and Jon B. Rousseau (?Employee?). RECITALS OF FACT The Company desires to recognize the critical skills and contribution provided by Employee to the Company and seeks to retain his services. This Agreement is entere

KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE

EXHIBIT 99.2 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE LOUISVILLE, Ky. (August 4, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors approved th

KINDRED HEALTHCARE REPORTS SECOND QUARTER 2016 RESULTS AT HIGH END OF GUIDANCE RANGE Company Reaffirms Full Year Outlook for 2016 Consolidated Revenues of $1.84 billion, GAAP Income from Continuing Operations of $34 million, GAAP Diluted EPS from Con

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS SECOND QUARTER 2016 RESULTS AT HIGH END OF GUIDANCE RANGE Company Reaffirms Full Year Outlook for 2016 Consolidated Revenues of $1.84 billion, GAAP Income from Continuing Operations of $34 million, GAAP Diluted EPS from Continuing Operations of $0.23 and EBITDAR of $251 million(1) in the Second

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2016 KINDRED HEALTHCARE

FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or

Regulation FD Disclosure, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or o

KINDRED HEALTHCARE AND SELECT MEDICAL HOLDINGS CORPORATION COMPLETE ACQUISITION OF ADDITIONAL HOSPITALS FROM EACH OTHER

EX-99.1 Exhibit 99.1 Contact: Todd Flowers Senior Vice President, Corporate Finance and Treasurer (502) 596-6569 KINDRED HEALTHCARE AND SELECT MEDICAL HOLDINGS CORPORATION COMPLETE ACQUISITION OF ADDITIONAL HOSPITALS FROM EACH OTHER LOUISVILLE, Ky. (June 28, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has completed the acquisition of an addition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2016 KINDRED HEALTHCARE,

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or o

[Remainder of Page Intentionally Left Blank]

EX-10.1 Exhibit 10.1 EXECUTION VERSION FIFTH AMENDMENT AND RESTATEMENT AGREEMENT dated as of June 14, 2016 (this “Amendment”), among KINDRED HEALTHCARE, INC., a Delaware corporation (the “Borrower”), the CONSENTING LENDERS (as defined below), each 2016 INCREMENTAL TERM LENDER (as defined below), JPMORGAN CHASE BANK, N.A., as administrative agent and collateral agent (the “Administrative Agent”) an

Fourth Amendment and Restatement Agreement dated as of June 14, 2016, by and among Kindred Healthcare, Inc., the Consenting Lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on June 15, 2016 (Comm. File No. 001-14057)).

EX-10.2 Exhibit 10.2 EXECUTION VERSION FOURTH AMENDMENT AND RESTATEMENT AGREEMENT dated as of June 14, 2016 (this “Amendment”), among KINDRED HEALTHCARE, INC., a Delaware corporation (the “Borrower”), the CONSENTING LENDERS (as defined below) and JPMORGAN CHASE BANK, N.A., as administrative agent (the “Administrative Agent”). RECITALS A. The Borrower, the Lenders party thereto from time to time an

KINDRED HEALTHCARE ANNOUNCES CLOSING OF INCREMENTAL TERM LOAN AND AMENDMENTS TO ITS CREDIT FACILITIES

Exhibit 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE ANNOUNCES CLOSING OF INCREMENTAL TERM LOAN AND AMENDMENTS TO ITS CREDIT FACILITIES LOUISVILLE, Ky. (June 14, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that it has closed its previously announced incremental $200 million term loan, the net proceeds of which were use

Regulation FD Disclosure, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or or

KINDRED HEALTHCARE COMPLETES SYNDICATION OF INCREMENTAL TERM LOAN AND SECURES CONSENT FOR AMENDMENTS TO CREDIT FACILITIES

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE COMPLETES SYNDICATION OF INCREMENTAL TERM LOAN AND SECURES CONSENT FOR AMENDMENTS TO CREDIT FACILITIES LOUISVILLE, Ky. (June 9, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced it has completed syndication and pricing of an incremental $200 million term loan, the

KINDRED HEALTHCARE AND SELECT MEDICAL HOLDINGS CORPORATION COMPLETE ACQUISITION OF HOSPITALS FROM EACH OTHER

EX-99.1 Exhibit 99.1 Contact: Todd Flowers Senior Vice President, Corporate Finance and Treasurer (502) 596-7514 KINDRED HEALTHCARE AND SELECT MEDICAL HOLDINGS CORPORATION COMPLETE ACQUISITION OF HOSPITALS FROM EACH OTHER LOUISVILLE, Ky. (June 1, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that it has completed the sale of two of its transitional care h

Regulation FD Disclosure, Financial Statements and Exhibits

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or or

KINDRED HEALTHCARE ANNOUNCES VOTING RESULTS FOR THE 2016 ANNUAL MEETING OF SHAREHOLDERS

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE ANNOUNCES VOTING RESULTS FOR THE 2016 ANNUAL MEETING OF SHAREHOLDERS LOUISVILLE, Ky. (May 25, 2016) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the voting results of the Company’s 2016 Annual Meeting of Shareholders held on May 25, 2016. At the annual meeting, the

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or or

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ¨ TRANSITION REPORT PURSUANT TO SE

0 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

EMPLOYEE RETENTION AGREEMENT

EXHIBIT 10.9 EMPLOYEE RETENTION AGREEMENT This Employee Retention Agreement (?Agreement?), dated as of March 30, 2016, is by and between Kindred Healthcare Operating, Inc. (the ?Company?) and David A. Causby (?Employee?). RECITALS OF FACT The Company desires to recognize the critical skills and contribution provided by Employee to the Company and seeks to retain his services. This Agreement is ent

KINDRED HEALTHCARE REPORTS FIRST QUARTER 2016 RESULTS Consolidated Revenues of $1.84 billion, Core EBITDAR of $247 million(1), Core Diluted EPS from Continuing Operations of $0.25(1) and Adjusted Core Diluted EPS from Continuing Operations of $0.35(1

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS FIRST QUARTER 2016 RESULTS Consolidated Revenues of $1.84 billion, Core EBITDAR of $247 million(1), Core Diluted EPS from Continuing Operations of $0.25(1) and Adjusted Core Diluted EPS from Continuing Operations of $0.35(1) in the First Quarter GAAP Diluted EPS from Continuing Operations of $0.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 KINDRED HEALTHCARE, I

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or org

KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.76 PER PREFERRED SHARE

Exhibit 99.2 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.76 PER PREFERRED SHARE LOUISVILLE, Ky. (May 4, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors approved the p

Kindred Healthcare DEFA14A

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) ¨ De

Kindred Healthcare DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) x Definitive

AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 2

EX-10.3 EXHIBIT 10.3 AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 2 THIS AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 2 (hereinafter, this “Amendment”) is executed as of April 3, 2016 (the “Amendment Execution Date”), and effective as of the 3rd day of April, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED P

AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1

EX-10.2 EXHIBIT 10.2 AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1 THIS AMENDMENT NO. 3 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1 (hereinafter, this “Amendment”) is executed as of April 3, 2016 (the “Amendment Execution Date”), and effective as of the 3rd day of April, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED P

AMENDMENT NO. 3 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5

EX-10.5 EXHIBIT 10.5 AMENDMENT NO. 3 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 THIS AMENDMENT NO. 3 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 (hereinafter, this “Amendment”) is executed as of April 3, 2016 (the “Amendment Execution Date”), and effective as of the 3rd day of April, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED PARTNERSHIP, a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2016 KINDRED HEALTHCARE,

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or o

KINDRED ADVANCES LTAC PORTFOLIO OPTIMIZATION STRATEGY WITH DEFINITIVE AGREEMENT TO SELL 12 LTAC HOSPITALS TO CURAHEALTH, LLC

EXHIBIT 99.1 Contact: Todd Flowers Senior Vice President, Corporate Finance and Treasurer (502) 596-7514 KINDRED ADVANCES LTAC PORTFOLIO OPTIMIZATION STRATEGY WITH DEFINITIVE AGREEMENT TO SELL 12 LTAC HOSPITALS TO CURAHEALTH, LLC LOUISVILLE, Ky. (April 4, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that it has signed a definitive agreement to sell 12 lo

AMENDMENT NO. 2 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5

EX-10.4 5 d173376dex104.htm EX-10.4 EXHIBIT 10.4 AMENDMENT NO. 2 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 THIS AMENDMENT NO. 2 TO AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 5 (hereinafter, this “Amendment”) is executed as of April 3, 2016 (the “Amendment Execution Date”), and effective as of the 3rd day of April, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REA

AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1

EX-10.1 EXHIBIT 10.1 AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1 THIS AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED MASTER LEASE AGREEMENT NO. 1 (hereinafter, this “Amendment”) is executed as of April 3, 2016 (the “Amendment Execution Date”), and effective as of the 3rd day of April, 2016 (the “Amendment Effective Date”) and is by and among VENTAS REALTY, LIMITED P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-14057 KINDRED HEALTHCARE, INC.

AGREEMENT

Exhibit 10.28 AGREEMENT This Agreement (?Agreement?) is between Kindred Healthcare Operating, Inc. (the ?Company?) and Stephen D. Farber (?Employee?). Whereas, the Company desires to offset relocation and other costs incurred by Employee in connection with his relocation to Louisville, Kentucky. In consideration of the premises and the mutual covenants contained herein, the following is agreed to

Change-in-Control Severance Agreement dated as of February 2, 2016 by and between Kindred Healthcare Operating, Inc. and David A. Causby (incorporated by reference to Exhibit 10.38 to Kindred’s Form 10-K for the year ended December 31, 2015 (Comm. File No. 001-14057)).

Exhibit 10.38 Change-in-Control Severance Agreement This Change-in-Control Severance Agreement (the ?Agreement?) is made as of the 2nd day of February, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?) and DAVID CAUSBY (the ?Employee?). Recitals: A. The Employee is employed by the Company, a wholly owned subsidiary of Kindred Hea

RESTRICTED SHARE AWARD AGREEMENT

Exhibit 10.78 RESTRICTED SHARE AWARD AGREEMENT THIS AGREEMENT, made as of this day of between Kindred Healthcare, Inc., a Delaware corporation and its successors (the ?Company?), and (the ?Non-Employee Director?). WHEREAS, the Company adopted and maintains the Kindred Healthcare, Inc. 2012 Equity Plan for Non-Employee Directors, Amended and Restated (the ?Plan?); WHEREAS, the Plan provides for the

NON-QUALIFIED STOCK OPTION GRANT AGREEMENT

Exhibit 10.79 NON-QUALIFIED STOCK OPTION GRANT AGREEMENT THIS AGREEMENT, made as of this day of , between Kindred Healthcare, Inc. (the ?Company?) and (the ?Non-Employee Director?). WHEREAS, the Company has adopted and maintains the Kindred Healthcare, Inc. 2012 Equity Plan for Non-Employee Directors , Amended and Restated (the ?Plan?); WHEREAS, the Plan provides for the grant to Non-Employee Dire

Employment Agreement dated as of January 1, 2016 by and between Kindred Healthcare Operating, Inc. and Joseph L. Landenwich (incorporated by reference to Exhibit 10.22 to Kindred’s Form 10-K for the year ended December 31, 2015 (Comm. File No. 001-14057)).

Exhibit 10.22 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the ?Agreement?) is made as of the 1st day of January, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?), and Joseph L. Landenwich (the "Executive"). W I T N E S S E T H: WHEREAS, the Executive is employed by the Company, a wholly-owned subsidiary of Kindred Healthcare

Kindred Healthcare, Inc. Director Fee Deferral Plan, effective as of January 1, 2016 (incorporated by reference to Exhibit 10.84 to Kindred’s Form 10-K for the year ended December 31, 2016 (Comm. File No. 001-14057)).

Exhibit 10.84 KINDRED HEALTHCARE, INC. DIRECTOR FEE DEFERRAL PLAN Purpose This Plan is designed to allow non-employee members of the Board of Directors of Kindred Healthcare, Inc. (the "Company") to defer receipt (and taxation) of fees that would otherwise be payable in cash. This Plan shall be unfunded for tax purposes and is intended to comply with Section 409A of the Code. Section 1?DEFINITIONS

REGISTRANT’S SUBSIDIARIES December 31, 2015

Exhibit 21 REGISTRANT?S SUBSIDIARIES December 31, 2015 Cornerstone Insurance Company, a Cayman Islands corporation Kindred Healthcare Operating, Inc.

Change-in-Control Severance Agreement dated as of January 1, 2016 by and between Kindred Healthcare Operating, Inc. and Peter K. Kalmey (incorporated by reference to Exhibit 10.34 to Kindred’s Form 10-K for the year ended December 31, 2015 (Comm. File No. 001-14057)).

Exhibit 10.34 Change-in-Control Severance Agreement This Change-in-Control Severance Agreement (the ?Agreement?) is made as of the 1st day of January 1, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?) and PETER K. KALMEY (the ?Employee?). Recitals: A. The Employee is employed by the Company, a wholly owned subsidiary of Kindred

Employment Agreement dated as of January 1, 2016 by and between Kindred Healthcare Operating, Inc. and Peter K. Kalmey (incorporated by reference to Exhibit 10.33 to Kindred’s Form 10-K for the year ended December 31, 2015 (Comm. File No. 001-14057)).

Exhibit 10.33 EMPLOYMENT AGREEMENT This EMPLOYMENT AGREEMENT (the ?Agreement?) is made as of the 1st day of January, 2016 (the ?Effective Date?), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the ?Company?), and Peter K. Kalmey (the "Executive"). W I T N E S S E T H: WHEREAS, the Executive is employed by the Company, a wholly-owned subsidiary of Kindred Healthcare, Inc

Amendment No. 4 to the Third Amendment and Restatement of the Kindred Deferred Compensation Plan, effective as of January 1, 2016 (incorporated by reference to Exhibit 10.12 to Kindred’s Form 10-K for the year ended December 31, 2015 (Comm. File No. 001-14057)).

Exhibit 10.12 AMENDMENT NO. 4 TO THE KINDRED DEFERRED COMPENSATION PLAN This is Amendment No. 4 to the Third Amendment and Restatement of the Kindred Deferred Compensation Plan, as last amended and restated as of January 1, 2009 (the "Plan"), which amendment shall be effective as of January 1, 2016. Recitals A. Kindred Healthcare, Inc. (the "Company") maintains the Plan and has reserved the right

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE

EXHIBIT 99.2 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE LOUISVILLE, Ky. (February 25, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors approved

KINDRED HEALTHCARE REPORTS FOURTH QUARTER 2015 RESULTS Consolidated Revenues of $1.8 billion, Core EBITDAR of $248 million(1), Core Diluted EPS from Continuing Operations of $0.33(1) and Adjusted Core Diluted EPS from Continuing Operations of $0.44(1

EX-99.1 EXHIBIT 99.1 Contact: Todd Flowers Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS FOURTH QUARTER 2015 RESULTS Consolidated Revenues of $1.8 billion, Core EBITDAR of $248 million(1), Core Diluted EPS from Continuing Operations of $0.33(1) and Adjusted Core Diluted EPS from Continuing Operations of $0.44(1) in the Fourth Quarter; GAAP Diluted EPS from Continuing Operations of $

KND / Kindred Healthcare, Inc. / North Tide Capital Master, LP - AMENDMENT NO. 2 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number:3235-0145 Expires: February 28, 2009 Estimated average burden hours per response… 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, $0.25 par value (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 20

KND / Kindred Healthcare, Inc. / Point72 Asset Management, L.P. - SCHEDULE 13G/A, #3 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* KINDRED HEALTHCARE, INC. (Name of Issuer) Common Stock, Par Value $0.25 Per Share (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the

KND / Kindred Healthcare, Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Kindred Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which th

Kindred Healthcare 8-K (Current Report/Significant Event)

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or org

KINDRED ANNOUNCES EXPANSION OF ITS HOME HEALTH OPERATIONS AND GROWTH IN FOUR INTEGRATED CARE MARKETS

EX-99.1 EXHIBIT 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED ANNOUNCES EXPANSION OF ITS HOME HEALTH OPERATIONS AND GROWTH IN FOUR INTEGRATED CARE MARKETS LOUISVILLE, Ky. (February 9, 2016) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced the expansion of its home health operations in South Carolina. In addi

KND / Kindred Healthcare, Inc. / VANGUARD GROUP INC Passive Investment

kindredhealthcareinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Kindred Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 494580103 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropri

Kindred Healthcare SCHEDULE 13G/A (Passive Acquisition of More Than 5% of Shares)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* KINDRED HEALTHCARE INC (Name of Issuer) Common Stock (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this

Kindred Healthcare ESP

Correspondence Dedicated to Hope, Healing and Recovery January 28, 2016 Via EDGAR United States Securities and Exchange Commission 100 F Street, NE Washington, D.

Corporate Integrity Agreement, effective as of January 11, 2016, by and between the Office of Inspector General of the Department of Health and Human Services, RehabCare Group, Inc. and Kindred Healthcare, Inc. (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on January 12, 2016 (Comm. File No. 001-14057)).

EX-10.2 Exhibit 10.2 CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND REHABCARE GROUP, INC. AND KINDRED HEALTHCARE, INC. I. PREAMBLE RehabCare Group Inc., (RehabCare) and Kindred Healthcare, Inc., (Kindred) hereby enter into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United State

SETTLEMENT AGREEMENT

EX-10.1 Exhibit 10.1 SETTLEMENT AGREEMENT This Settlement Agreement (Agreement) is entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS) (collectively the ?United States?), RehabCare Group, Inc., and RehabCare Group East, Inc. (collective

KINDRED ANNOUNCES SETTLEMENT WITH THE UNITED STATES DEPARTMENT OF JUSTICE OVER REHABCARE INVESTIGATION

EX-99.1 EXHIBIT 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED ANNOUNCES SETTLEMENT WITH THE UNITED STATES DEPARTMENT OF JUSTICE OVER REHABCARE INVESTIGATION LOUISVILLE, Ky. (January 12, 2016) ? Kindred Healthcare, Inc. (the ?Company?) (NYSE:KND) today announced that it has entered into a settlement agreement with the United States Department

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 d111255d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2016 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of

KND / Kindred Healthcare, Inc. / CARLSON CAPITAL L P - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Kindred Healthcare, Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 494580103 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the

KINDRED APPOINTS JOSEPH L. LANDENWICH AS GENERAL COUNSEL AND CORPORATE SECRETARY

EX-99.1 2 d103761dex991.htm EX-99.1 EXHIBIT 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED APPOINTS JOSEPH L. LANDENWICH AS GENERAL COUNSEL AND CORPORATE SECRETARY LOUISVILLE, Ky. (December 22, 2015) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the appointment of Joseph L. Landenwich as General Counsel an

Kindred Healthcare FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

Kindred Healthcare FORM 8-K (Current Report/Significant Event)

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

Kindred Healthcare ESP

CORRESP 1 filename1.htm December 22, 2015 Via EDGAR United States Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Attention: Mr. Carlos Pacho, Senior Assistant Chief Accountant Re: Kindred Healthcare, Inc. Form 10-K for Fiscal Year Ended December 31, 2014 Filed March 2, 2015 File No. 1-14057 Dear Mr. Pacho: Kindred Healthcare, Inc. (“Kindred” or the “Company”) has receiv

KINDRED APPOINTS PETER K. KALMEY AS PRESIDENT OF ITS HOSPITAL DIVISION

EX-99.1 EXHIBIT 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED APPOINTS PETER K. KALMEY AS PRESIDENT OF ITS HOSPITAL DIVISION LOUISVILLE, Ky. (December 21, 2015) – Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced the appointment of Peter K. Kalmey as President of its Hospital Division, effective January 1, 2016

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ¨ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to .

KINDRED HEALTHCARE REPORTS THIRD QUARTER 2015 RESULTS Consolidated Revenues of $1,765 million, Core EBITDAR of $236 million(1) and Core Diluted EPS from Continuing Operations of $0.23(1) in the Third Quarter GAAP Operating Income of $197 million(1) a

EX-99.1 Exhibit 99.1 Contact: Susan E. Moss Investor Relations (502) 596-6569 KINDRED HEALTHCARE REPORTS THIRD QUARTER 2015 RESULTS Consolidated Revenues of $1,765 million, Core EBITDAR of $236 million(1) and Core Diluted EPS from Continuing Operations of $0.23(1) in the Third Quarter GAAP Operating Income of $197 million(1) and Diluted Loss Per Share from Continuing Operations of $0.20 in the Thi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2015 KINDRED HEALTHCA

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation o

KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE

Exhibit 99.2 Contact: Susan E. Moss Investor Relations (502) 596-6569 KINDRED HEALTHCARE BOARD OF DIRECTORS DECLARES CASH DIVIDEND OF $0.12 PER COMMON SHARE AND APPROVES SCHEDULED PREFERRED STOCK INSTALLMENT PAYMENT OF $18.75 PER PREFERRED SHARE LOUISVILLE, Ky. (November 4, 2015) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors approved

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or org

KINDRED ANNOUNCES APPOINTMENT OF DR. SHARAD MANSUKANI TO BOARD OF DIRECTORS

EX-99.1 EXHIBIT 99.1 Contact: Susan E. Moss Senior Vice President, Marketing and Communications (502) 596-7296 KINDRED ANNOUNCES APPOINTMENT OF DR. SHARAD MANSUKANI TO BOARD OF DIRECTORS LOUISVILLE, Ky. (October 29, 2015) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced that its Board of Directors has appointed Dr. Sharad Mansukani to the Board effective immediate

Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.1 to Kindred’s Current Report on Form 8-K filed on October 30, 2015 (Comm. File No. 001-14057)).

EX-3.1 EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OF KINDRED HEALTHCARE, INC. ARTICLE I Stockholders Section 1.1. Annual Meetings. An annual meeting of stockholders shall be held for the election of directors at such date, time and place either within or without the State of Delaware as may be designated by the Board of Directors from time to time. Subject to Section 1.11, any other proper business m

KINDRED HEALTHCARE ANNOUNCES RESULTS OF THE EXCHANGE OFFER FOR ITS 8.00% SENIOR NOTES DUE 2020 AND ITS 8.75% SENIOR NOTES DUE 2023

EX-99.1 EXHIBIT 99.1 Contact: Susan E. Moss Investor Relations (502) 596-6569 KINDRED HEALTHCARE ANNOUNCES RESULTS OF THE EXCHANGE OFFER FOR ITS 8.00% SENIOR NOTES DUE 2020 AND ITS 8.75% SENIOR NOTES DUE 2023 LOUISVILLE, Ky. (October 29, 2015) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced the final results of its registered exchange offer (the ?Exchange Offer?)

Financial Statements and Exhibits, Other Events

8-K 1 d28847d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of

Kindred Healthcare, Inc. Offer to Exchange any and all of our outstanding unregistered 8.00% Senior Notes due 2020 for $750,000,000 aggregate principal amount of our new 8.00% Senior Notes due 2020 that have been registered under the Securities Act o

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-206995 PROSPECTUS Kindred Healthcare, Inc. Offer to Exchange any and all of our outstanding unregistered 8.00% Senior Notes due 2020 for $750,000,000 aggregate principal amount of our new 8.00% Senior Notes due 2020 that have been registered under the Securities Act of 1933, as amended (the ?Securities Act?) Offer to Exchange

KINDRED HEALTHCARE COMMENCES REGISTERED EXCHANGE OFFER FOR ITS 8.00% SENIOR NOTES DUE 2020 AND 8.75% SENIOR NOTES DUE 2023

EX-99.1 Exhibit 99.1 Contact: Susan E. Moss Investor Relations (502) 596-6569 KINDRED HEALTHCARE COMMENCES REGISTERED EXCHANGE OFFER FOR ITS 8.00% SENIOR NOTES DUE 2020 AND 8.75% SENIOR NOTES DUE 2023 LOUISVILLE, Ky. (September 29, 2015) ? Kindred Healthcare, Inc. (?Kindred? or the ?Company?) (NYSE:KND) today announced the commencement of an exchange offer for all of its outstanding 8.00% Senior N

Financial Statements and Exhibits, Other Events

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

September 24, 2015

CORRESP 1 filename1.htm September 24, 2015 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Lahdan Rahmati, Esq. Re: Kindred Healthcare, Inc. Registration Statement on Form S-4 (File No. 333-206995) Dear Ms. Rahmati: With respect to the above-referenced registration statement (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promul

Kindred Healthcare, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges (In thousands, except statistics) Year Ended December 31, Six Months ended June 30, 2015 2010 2011 2012 2013 2014 COMPUTATION OF FIXED CHARGES: Interest expensed

Exhibit 12.1 Kindred Healthcare, Inc. Statement of Computation of Ratio of Earnings to Fixed Charges (In thousands, except statistics) Year Ended December 31, Six Months ended June 30, 2015 2010 2011 2012 2013 2014 COMPUTATION OF FIXED CHARGES: Interest expensed and capitalized in continuing operations, including amortization of debt discounts and fees $ 8,270 $ 82,355 $ 110,235 $ 108,082 $ 168,78

Unaudited pro forma condensed combined financial data

Exhibit 99.3 Unaudited pro forma condensed combined financial data The following unaudited pro forma condensed combined financial data for the year ended December 31, 2014 and the six months ended June 30, 2015 is based upon the historical consolidated financial data of Kindred Healthcare, Inc. and its consolidated subsidiaries (?Kindred?, ?we? or ?our?) and Gentiva Health Services, Inc. and its c

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2015 KINDRED HEALTH

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation

As filed with the Securities and Exchange Commission on September 17, 2015

Table of Contents As filed with the Securities and Exchange Commission on September 17, 2015 Registration No.

CENTERRE HEALTHCARE CORPORATION AND SUBSIDIARIES TABLE OF CONTENTS Page Report of Independent Registered Public Accounting Firm 2 Consolidated Financial Statements: Consolidated Statement of Operations and Comprehensive Income (Loss) for the year end

EX-99.1 Exhibit 99.1 CENTERRE HEALTHCARE CORPORATION AND SUBSIDIARIES TABLE OF CONTENTS Page Report of Independent Registered Public Accounting Firm 2 Consolidated Financial Statements: Consolidated Statement of Operations and Comprehensive Income (Loss) for the year ended December 31, 2014 3 Consolidated Balance Sheet as of December 31, 2014 4 Consolidated Statement of Shareholders’ Equity for th

List of Subsidiaries

Exhibit 21.1 List of Subsidiaries Cornerstone Insurance Company, a Cayman Islands corporation Kindred Healthcare Operating, Inc., a Delaware corporation Homestead Health and Rehabilitation Center, L.L.C., a Delaware limited liability company Kindred Development 27, L.L.C., a Delaware limited liability company Kindred Development 29, L.L.C., a Delaware limited liability company Kindred Healthcare D

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE

Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A National Banking Associ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2015 KINDRED HEALTH

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2015 KINDRED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-14057 61-1323993 (State or other jurisdiction of incorporation or organ

LEASE SEVERANCE AND AMENDMENT AGREEMENT BY AND AMONG KINDRED HEALTHCARE, INC. (f/k/a Vencor, Inc.), KINDRED HEALTHCARE OPERATING, INC. (f/k/a Vencor Operating, Inc.), VENTAS REALTY, LIMITED PARTNERSHIP, CCP WIND RIVER 0482 LLC CCP CHEYENNE 0441 LLC L

Exhibit 10.44 LEASE SEVERANCE AND AMENDMENT AGREEMENT BY AND AMONG KINDRED HEALTHCARE, INC. (f/k/a Vencor, Inc.), KINDRED HEALTHCARE OPERATING, INC. (f/k/a Vencor Operating, Inc.), VENTAS REALTY, LIMITED PARTNERSHIP, CCP WIND RIVER 0482 LLC AND CCP CHEYENNE 0441 LLC LEASE SEVERANCE AND AMENDMENT AGREEMENT THIS LEASE SEVERANCE AND AMENDMENT AGREEMENT (hereinafter, this ?Agreement? ) is dated as of

HEALTHCARE OPERATIONS

Exhibit 99.1 Item 1. Business All references in this Current Report on Form 8-K to “Kindred,” “the Company,” “we,” “us,” or “our” mean Kindred Healthcare, Inc. and, unless the context otherwise requires, our consolidated subsidiaries. GENERAL Kindred Healthcare, Inc. is a healthcare services company that through its subsidiaries operates transitional care (“TC”) hospitals, a home health and hospic

LEASE SEVERANCE AND AMENDMENT AGREEMENT BY AND AMONG KINDRED HEALTHCARE, INC. (f/k/a Vencor, Inc.), KINDRED HEALTHCARE OPERATING, INC. (f/k/a Vencor Operating, Inc.), VENTAS REALTY, LIMITED PARTNERSHIP CCP RAWLINS 0481 LLC LEASE SEVERANCE AND AMENDME

Exhibit 10.50 LEASE SEVERANCE AND AMENDMENT AGREEMENT BY AND AMONG KINDRED HEALTHCARE, INC. (f/k/a Vencor, Inc.), KINDRED HEALTHCARE OPERATING, INC. (f/k/a Vencor Operating, Inc.), VENTAS REALTY, LIMITED PARTNERSHIP AND CCP RAWLINS 0481 LLC LEASE SEVERANCE AND AMENDMENT AGREEMENT THIS LEASE SEVERANCE AND AMENDMENT AGREEMENT (hereinafter, this ?Agreement? ) is dated as of the 7th day of August, 201

GENTIVA HEALTH SERVICES, INC. AND SUBSIDIARIES INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page No. Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets as of December 31, 2014 and 2013 1 Consolidated Statements of Compr

EX-99.2 Exhibit 99.2 GENTIVA HEALTH SERVICES, INC. AND SUBSIDIARIES INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page No. Report of Independent Registered Public Accounting Firm Consolidated Balance Sheets as of December 31, 2014 and 2013 1 Consolidated Statements of Comprehensive Income (Loss) for each of the three years in the period ended December 31, 2014 2 Consolidated Statements of Changes in

Kindred Healthcare ESP

Correspondence September 17, 2015 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

Second Supplemental Indenture, dated as of April 13, 2015, among Kindred Healthcare, Inc., the Subsidiary Guarantor party thereto and Wells Fargo Bank, National Association, as trustee (2020 Notes) (incorporated by reference to Exhibit 4.1 to the Company’s Form 10-Q for the quarterly period ended June 30, 2015 (Comm. File No. 001-14057)).

EXHIBIT 4.1 SECOND SUPPLEMENTAL INDENTURE (this ?Supplemental Indenture?), dated as of April 13, 2015, among Kindred Healthcare, Inc. (the ?Company?), Physician Housecalls, LLC, a Colorado limited liability company (the ?New Subsidiary Guarantor?), and Wells Fargo Bank, National Association, as trustee (the ?Trustee?). W I T N E S S E T H: WHEREAS, each of Kindred Escrow Corp. II, a Delaware corpo

Second Supplemental Indenture, dated as of February 2, 2015, among Kindred Healthcare, Inc., the Subsidiary Guarantors party thereto and Wells Fargo Bank, National Association, as trustee (2022 Notes) (incorporated by reference to Exhibit 4.3 to the Company’s Form 10-Q for the quarterly period ended June 30, 2015 (Comm. File No. 001-14057)).

EXHIBIT 4.3 SECOND SUPPLEMENTAL INDENTURE (this ?Supplemental Indenture?), dated as of February 2, 2015, among Kindred Healthcare, Inc. (the ?Company?), each of the subsidiary guarantors listed on the signature pages hereto (each a ?New Subsidiary Guarantor? and, collectively, the ?New Subsidiary Guarantors?), and Wells Fargo Bank, National Association, as trustee (the ?Trustee?). W I T N E S S E

Third Supplemental Indenture, dated as of June 5, 2015, among Kindred Healthcare, Inc., the Subsidiary Guarantor party thereto and Wells Fargo Bank, National Association, as trustee (2020 Notes) (incorporated by reference to Exhibit 4.2 to the Company’s Form 10-Q for the quarterly period ended June 30, 2015 (Comm. File No. 001-14057)).

EXHIBIT 4.2 THIRD SUPPLEMENTAL INDENTURE (this ?Supplemental Indenture?), dated as of June 5, 2015, among Kindred Healthcare, Inc. (the ?Company?), House Call Doctors, Inc., a Texas corporation (the ?New Subsidiary Guarantor?), and Wells Fargo Bank, National Association, as trustee (the ?Trustee?). W I T N E S S E T H: WHEREAS, each of Kindred Escrow Corp. II, a Delaware corporation and a wholly-o